ORGANIC
LETTERS
2003
Vol. 5, No. 23
4441-4444
Synthesis of the Integrastatin Nucleus
Using the Ramberg−Ba1cklund Reaction
,†
Jonathan S. Foot,† Gerard M. P. Giblin,‡ and Richard J. K. Taylor*
Department of Chemistry, UniVersity of York, Heslington, York, YO10 5DD, UK, and
Department of Medicinal Chemistry, Neurology and GI CEDD, GlaxoSmithKline,
The Frythe, Welwyn, Herts AL6 9AR, UK
Received September 16, 2003
ABSTRACT
The first synthesis of the tetracyclic nucleus of the Integrastatins, natural products that have been shown to selectively inhibit HIV-1 integrase,
is reported. Key steps of this synthesis involve a novel cis-selective Ramberg−Ba1cklund reaction and an unusual Lewis acid-promoted cyclization
step.
Integrastatin A (1a) and B (1b) (Scheme 1) are two recently
discovered natural products isolated from both an unnamed
contain two chiral centers, they exist in nature in racemic
form ((R,R)-form shown).
As part of our ongoing interest in the synthesis of highly
oxygenated natural products,2 it was decided to investigate
the total synthesis of both Integrastatins. Given the novel
structure of the tetracyclic nucleus 2, we first explored
synthetic approaches to this simplified analogue by func-
tionalization of alkene 3, obtained by retrosynthetic analysis
(Scheme 1).
Scheme 1. Integrastatins A & B and the Integrastatin
Tetracyclic Nucleus, 2
Failure of Wittig, Grignard, Julia, and lithiation chemistries
to produce 3 led us to the Ramberg-Ba¨cklund reaction
(RBR).3
To this end, the two coupling partners 6 and 7 (Scheme
2) were synthesized from the commercially available 2-me-
thylacetophenone (4) and 2-hydroxyacetophenone (5). Cou-
pling and oxidation of the resultant thioether proceeded
smoothly to afford the sulfone 9 in 52% yield overall.
Sulfone 9 was then subjected to the in situ chlorination-
Ramberg-Ba¨cklund reaction using the conditions described
fungal source (ATCC74478) and from an endophytic Asco-
chtya species (ATCC74477), which have been found to
selectively inhibit the strand-transfer reaction of recombinant
HIV-1 integrase at micromolar concentrations.1 They are
based on a novel [6.6.6.6] tetracycle, and although they
(1) Singh, S. B.; Fink. D. L.; Quamina, D. S.; Pelaez, F.; Teran, A.;
Felock, P.; Hazuda, D. J. Tetrahedron Lett. 2002, 43, 2351.
(2) (a) Harvey, J. E.; Raw, S. A.; Taylor, R. J. K. Tetrahedron Lett.
2003, 44, 7209. (b) Lewis, A.; Stefanuti, I.; Swain, S. A.; Smith, S. A.;
Taylor, R. J. K. Org. Biomol. Chem. 2003, 1, 104. (c) Runcie, K. A.; Taylor,
R. J. K. Org. Lett. 2001, 3, 3237. (d) Ragot, J. P.; Taylor, R. J. K. Org.
Lett. 2000, 2, 1981. (e) Alcevaz, L.; MacDonald, G.; Ragot, J.; Lewis, N.
J.; Taylor, R. J. K. Tetrahedron 1999, 55, 3707 and references therein.
(3) (a) Ramberg, L.; Ba¨cklund, B. ArkiV Kemi. Mineral. Geol. 1940, 27,
13A. (b) Casy, G.; Taylor, R. J. K. Org. React. 2003, 62, 357.
† University of York.
‡ GlaxoSmithKline.
10.1021/ol035786v CCC: $25.00 © 2003 American Chemical Society
Published on Web 10/11/2003